Michael S. Cuffe, EVP and Chief Clinical Officer at HCA Healthcare, Inc. (HCA), sold 14,756 shares at $418.84 ($6.1M) on 2025-09-08, disclosed to the SEC on 2025-09-08.
Scheduled sale ($6.1M) by EVP and Chief Clinical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $411.59 | 7,084 | $2.9M | 47.6% |
| 2 | $418.84 | 3,836 | $1.6M | 26.2% |
| 3 | $418.84 | 3,836 | $1.6M | 26.2% |
| Total | $415.36 avg | 14,756 | $6.1M | 100% |
| Filing → |
| HCA | SELL | 2024-05-13 | $4.0M | — | Filing → |
| HCA | SELL | 2024-05-08 | $494K | — | Filing → |
| HCA | SELL | 2024-02-02 | $2.0M | — | Filing → |